The present project aimed to estimate bioavailability of dietary vitamin B 12 , for which little information is available in growing pigs. Two approaches, each using 2 quantities of dietary cyanocobalamin, were compared; the first was based on whole body retention for 8 d and the second was based on nycthemeral portal net flux of vitamin B 12 . In the first trial, 15 blocks of 3 pigs (31.7 ± 0.5 kg of BW) were formed according to their vitamin B 12 status. Within each block, 1 pig (CONT) was killed and tissues were sampled for vitamin B 12 determination. The remaining 2 piglets were fed 25 (B 12 -25) or 250 (B 12 -250) μg daily of cyanocobalamin for 8 d. Urine was sampled twice daily, and the pigs were killed and sampled as CONT pigs. The total content of vitamin B 12 in the carcass, urine, and intestinal tract was affected by the dietary treatments (P < 0.01) but not in the liver (P > 0.019). The whole body retention of vitamin B 12 was greater (P = 0.02) in B 12 -250 than B 12 -25 pigs, but the corresponding bioavailability was estimated to be 5.3 and 38.2%, respectively. In trial 2, 11 pigs (35.1 ± 4.0 kg of BW and 75.4 ± 5.9 d of age) fed a diet unsupplemented with vitamin B 12 from weaning at 28 d of age were surgically equipped with catheters in the portal vein and carotid artery and an ultrasonic flow probe around the portal vein. Each pig received 3 boluses of 0 (B 12 -0), 25, and 250 μg of dietary vitamin B 12 according to a crossover design. Postprandial nycthemeral arterial plasma concentrations of vitamin B 12 reached minimum values (P < 0.01) between 15 and 18 h postmeal that were 29.6, 15.6, and 10.0% less than the premeal values for B 12 -0, B 12 -25, and B 12 -250 pigs, respectively (linear, P < 0.01). The cumulative net flux of vitamin B 12 for 24 h corresponded to 2.4 and 5.1 μg for B 12 -25 and B 12 -250 treatments, respectively, and the corresponding bioavailability was estimated to be 9.7 and 2.0%, respectively. Although bioavailability estimates varied according to approaches, both showed the inverse relationship between dietary vitamin B 12 and bioavailability of the vitamin. The dietary supplement of 25 μg was sufficient to maximize hepatic vitamin B 12 retention and to attenuate the nycthemeral decrease of arterial plasma concentration of the vitamin.
INTRODUCTION
Estimates of dietary vitamin B 12 requirements in postweaning pigs are based on studies carried out before 1966 (NRC, 1998) and vary from 15 to 20 μg/kg. Typical amounts used by the feed industry range between 20 and 30 μg/kg (BASF, 2001) . Recently, House and Fletcher (2003) and Giguère et al. (2008) showed that supplements of 35 and 25 μg/kg of vitamin B 12 would be required in weaner or grower-finisher pigs, respectively. In gilts, Simard et al. (2007) showed that when dietary vitamin B 12 increased 10 times, from 20 to 200 μg/kg, vitamin B 12 in blood plasma was doubled. This indicated that vitamin B 12 bioavailability in pigs (defined as the fraction that can be absorbed across the
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in growing pigs 1 intestinal wall and then used for metabolic purposes) decreased with increased dietary concentrations, as in humans or others species (Combs, 1998) . Information on bioavailability of vitamin B 12 in pigs is limited. Ford et al. (1975) estimated the daily absorption capacity at approximately 10 μg in young pigs, whereas the corresponding values in adult humans would be 1.5 to 2.0 μg (Scott, 1997) . Dietary vitamin B 12 is almost exclusively provided by the synthetic and stable form, cyanocobalamin, because plant feedstuffs in most pig diets are devoid of the vitamin. Estimation of bioavailability of cyanocobalamin is essential for a reliable estimation of the most suitable dietary allowance of vitamin B 12 . Moreover, intestinal fate of cyanocobalamin should be investigated fully because growth performance of young pigs was enhanced by at least 12% after a parenteral administration of the vitamin (Wilson et al., 1991) .
In the present study, 2 approaches were used to determine bioavailability of 2 quantities of dietary cyanocobalamin in growing pigs. The first approach was based on whole body retention and urine excretion after 8 d of supplementation, whereas the second approach was based on the quantification of the net flux of vitamin B 12 through the portal-drained viscera after ingestion of a single supplemented meal.
MATERIALS AND METHODS
For both trials, the experimental procedures followed the guidelines of the Canadian Council on Animal Care (1993) and were approved by the Institutional Animal Care Committee of the Dairy and Swine Research and Development Centre of Sherbrooke (Québec, Canada). All animals were cared for and slaughtered according to the recommended code of practice of Agriculture Canada (1993) .
Trial 1
Animals and Diet. Forty-five castrated male piglets (Yorkshire-Landrace × Duroc) were weaned at 28 d of age and fed ad libitum a diet not supplemented with vitamin B 12 (Table 1) for a period of at least 6 wk. At 8 wk of age, a blood sample was collected from each animal in disposable evacuated tubes containing EDTA as the anticoagulant (Becton Dickinson, Franklin Lakes, NJ), centrifuged for 10 min at 4°C (1,800 × g), and the plasma was frozen at −20°C for subsequent vitamin B 12 determination. The animals were assigned to 15 blocks (replications) of 3 animals each based on their calculated total amount of vitamin B 12 in plasma, which was based on plasma vitamin B 12 concentration and an estimated plasma volume (4% of BW) as described by Simard et al. (2007) .
Treatments and Tissue Sampling. All piglets were transferred to a metabolic cage and fed 1.2 kg of the basal diet (Table 1) and 2.4 L of water per d for 1 wk. After this adaptation period, 1 pig (CONT) in each block was randomly selected and killed using a captive bolt followed by exsanguination. The liver was collected (gallbladder removed) and weighed; samples of approximately 1 g were collected from the 3 main lobes and frozen at -20°C. The digestive tract (including stomach and small and large intestines) was flushed of its contents and frozen at -20°C. The carcass (including mesenteric tissue and blood) was weighed and also stored at -20°C.
Within each block, the remaining 2 piglets were maintained on the same basal regimen as during the adaptation period for an additional 8 d. During this last period, pigs were offered a 50-g pellet made of the basal diet mixed with unsweetened apple sauce to induce rapid consumption and 25 μg (B 12 -25) or 250 μg (B 12 -250) of cyanocobalamin (V-2876, Sigma-Aldrich, St. Louis, MO), corresponding to 20 or 200 μg/kg of diet, before the daily meal. Urine was collected twice daily at 0800 and 1600 h into dark glass bottles (4 L) containing 10 mL of 1% NaCN (S-3296, Sigma-Aldrich) to stabilize all vitamin B 12 forms into cyanocobalamin for 2 d before initiation of treatments and during the treatment period (8 d). At collection time, urine volume was measured and a sample was frozen at -20°C. At the end of the collection period, all pigs were killed and measurements and samplings were done as described for CONT pigs.
Sample Preparation and Vitamin B 12 Analysis. The frozen carcasses were first coarsely cut into about 10 cm slices, which were ground together and passed 3 times through a meat grinder (model Autio-1101, Autio Company Inc., Astoria, OR) equipped with a circular plate measuring 25 cm in diameter with 6-mm diameter openings. A representative sample of each carcass (approximately 1 kg) was then collected and placed in molds of 1 cm 3 and refrozen at -20°C. These samples were further ground to ≤1 mm in a centrifugal grinder (model ZM-1, Sybron Brinkman Instruments Canada Ltd., Mississauga, Ontario, Canada), which was located in a freezer, and liquid nitrogen was used to keep the sample frozen. The same procedure was used for the digestive tract.
For vitamin B 12 determination, carcass (500 mg), digestive tract (500 mg), and liver (250 mg) samples were homogenized in a glass grinder tube with 4 mL of sodium acetate buffer (0.1 M, pH 4.6). One mililiter of this homogenate was incubated in a water bath at 60°C for 5 min.
One mililiter of a papain (P-3250, Sigma-Aldrich) solution (50 mg/mL) and 75 μL of 1% NaCN were added and incubated in a water bath at 60°C for 1 h. The mixture was then autoclaved at 121°C for 10 min and cooled in an ice-cold water bath. The pH was adjusted to 4.6 with approximately 100 μL of 0.2 N HCl, and the mixture was centrifuged at 1,800 × g for 13 min at 4°C. The supernatant was collected, with the pH adjusted to 6.5 with approximately 300 μL of 0.1 N NaOH, and centrifuged again at 11,000 × g for 5 min at 4°C. Two homogenates were prepared for each tissue sample and vitamin B 12 was determined in duplicate for each homogenate (interassays), with 200 μL of this supernatant diluted [1:8 (vol/vol) in water for liver] or undiluted (carcass and digestive tract), using a radioassay procedure (Quantaphase II B 12 , Bio-Rad Diagnostics Group, Hercules, CA), for which pig intrinsic factor as the vitamin B 12 binding protein. For urine, a 200-μL was used directly in the radioassay procedure, and vitamin B 12 was also determined in duplicate. Intra-and interassay CV, respectively, were 4.3 (n = 30) and 2.1% (n = 30) for liver, 3.5 (n = 13) and 2.2% (n = 11) for carcass, 6.0 (n = 13) and 5.8% (n = 16) for digestive tract, and 4.1 (n = 15) and 2.6% (n = 18) for urine.
Calculations and Statistical Analysis. The liver, digestive tract, and carcass contents of vitamin B 12 (total fresh weight × sample concentration) were calculated for each pig. For each B 12 -25 or B 12 -250 pig, urinary excretion of vitamin B 12 was calculated as the amount excreted (vitamin concentration × urine volume) during the experimental period of 8 d minus the average daily excretion measured 2 d before the initiation of treatments. Similarly, vitamin B 12 retention in each body portion of B 12 -25 and B 12 -250 pigs was calculated as the amount measured in these animals minus the amount present in tissues of the CONT pig within the same block. The total amount of vitamin B 12 absorbed corresponded to the summation of retention and urinary excretion. The bioavailability of dietary cyanocobalamin was expressed in percentage as follows: [(vitamin B 12 retention + vitamin B 12 urinary excretion)/vitamin B 12 intake] × 100.
All variables were analyzed as a randomized complete block design, with 2 treatments in 15 blocks, using the MIXED procedure (SAS Inst. Inc., Cary, NC). Results were reported as means and SE. The significance level was defined at P ≤ 0.05, and trends toward significance were considered at 0.05 < P ≤ 0.10.
Trial 2
Animals, Surgery, and Diet. After weaning at 28 d of age, 11 female piglets (Yorkshire-Landrace × Duroc) were fed ad libitum a diet not supplemented with vitamin B 12 (Table 1) for approximately 47 d before surgical modification. Average BW and age at surgery were 35.1 ± 4.0 kg and 75.4 ± 5.9 d, respectively. The surgical procedure has been described by Hooda et al. (2009) . Briefly, the animals were equipped with an ultrasonic flow probe (14 mm flow probe, SB-series, Transonic Systems Inc., Ithaca, NY) around the portal vein and a catheter inside the portal vein at 3.5 and 2.5 cm from the liver, respectively. Another catheter was inserted through the carotid artery up to the junction between carotid and subclavian arteries.
Treatments and Collection of Samples. After surgery, the animals were penned (1 × 1.8 m) individually and fed a single daily meal of 1.2 kg of the diet (Table 1) . During the whole experimental period, catheters were rinsed 3 times per week with heparinized saline (200 IU/mL) complemented with sodium penicillin (5,000 IU/mL). Ten to fifteen days after the surgery, or when the animals had recovered full appetite and normal growth rate, they were adapted to the metabolic cage (with free access to water) and consumption of a semi-purified diet (1.2 kg/d) containing 67.48% cornstarch, 16.20% vitamin-free casein (C-3400, SigmaAldrich), 10.77% sucrose, 4.30% dicalcium phosphate, 0.51% salt, and 0.72% limestone. The semi-purified diet was used only for experimental meals in an attempt to uniformize and minimize the duration of ingestion and its impact on the nycthemeral profiles. Each animal received the 3 experimental treatments according to a crossover design. The treatments were given as a 50-g pellet as described for trial 1, providing 0 (B 12 -0), 25 (B 12 -25), or 250 μg (B 12 -250) of dietary cyanocobalamin (V-2876, Sigma-Aldrich) just before the meal (1.2 kg of the semi-purified diet). On the experimental day, blood samples (4 mL) were collected simultaneously from the 2 catheters 15 and 5 min before the meal, every 45 min for the first 3 h postfeeding, and every hour for the next 21 h. Portal blood flow was recorded continuously for 24 h (WinDaq software, Dataq Instruments Inc., Akron, OH). Between experimental days (n = 3 for each pig), the animals were moved back to their pen for 3 to 4 d and fed the basal diet (Table 1) .
Sample Preparation and Analysis. Immediately after sampling, blood was transferred from the syringes to EDTA-treated tubes (Vacutainer, Becton Dickinson, Franklin Lakes, NJ). Plasma was collected after centrifugation at 1,800 × g for 10 min at 4°C and frozen at -20°C for further analysis. Plasma concentration of vitamin B 12 was measured by radioassay in duplicate with 200 μL as described by Simard et al. (2007) . Packed cell volume (PCV) was measured in duplicate on fresh blood by microcentrifugation, whereas an aliquot of blood was immediately frozen for hemoglobin determination according to the method of Drabkin (Manet, 1969) . Blood hemoglobin concentrations and PCV values were used for calculation of venous and arterial plasma flows from the recorded blood flow as described by Hooda et al. (2009) .
Calculations and Statistical Analysis. The net flux of vitamin B 12 across the portal-drained viscera was calculated as described by Girard et al. (2001) for each sampling time. A positive net flux indicates a release of a nutrient from the portal-drained viscera, whereas a negative flux indicates an uptake. Arterial concentrations and net flux of vitamin B 12 across the portal-drained viscera recorded 15 and 5 min before the meal were averaged and used as time 0. Arterial concentrations and net flux of vitamin B 12 across the portal-drained viscera were analyzed using the MIXED procedure of SAS according to crossover design, and pigs, periods, and treatments (unequally spaced) were included in the model along with repeated measures in time. Because the time intervals were unequally spaced, the following covariance structures were compared: space(power), space(Gaussian), space(exponential), space(linear), space(linear logarithmic), and space(spherical).
For each variable, the statistical analysis retained was with the best fit statistic value. Results are reported as least squares means and SEM. Values were assumed to be different at P ≤ 0.05 and tended to differ at P ≤ 0.10.
RESULTS AND DISCUSSION

Trial 1
In carcass, vitamin B 12 concentration and total content increased (P < 0.01) with the dietary intake of vitamin B 12 (Table 2) . Giguère et al. (2008) reported that vitamin B 12 concentrations in LM of 10-wk-old pigs were 3.7 and 4.1 ng/g after a long-term (8 wk) dietary supplementation of cyanocobalamin at 25 and 150 μg/ kg, respectively. The present carcass values included mainly muscles but also other metabolic pools such as blood, bone marrow, and other organs that might have contributed to greater vitamin B 12 concentrations compared with Giguère et al. (2008) because, according to Scheid and Schweigert (1954) , concentrations of vitamin B 12 in kidneys, pancreas, spleen, heart, brain, and lungs of pigs vary between 21 and 165 ng/g.
In liver, vitamin B 12 concentration and total content did not respond (P > 0.19) to dietary cyanocobalamin supplementation. The result contrasted with Catron et al. (1952) who found that the concentration of vitamin B 12 in liver increased from 49 to 135 ng/g with dietary vitamin B 12 supplementation at 0 and 13.2 μg/kg. The hepatic concentration of 150 ng/g in CONT pigs was possibly at the saturation threshold for vitamin B 12 content in liver. It seems that the postweaning period, during which the animals were fed the diet unsupplemented with vitamin B 12 (approximately 8 wk), was not sufficient to deplete liver reserves. Body reserves of vitamin B 12 are used up slowly (several months) in most species (Le Grusse and Watier, 1993; Combs, 1998) , including pigs where a slow hepatic release and metabolic utilization of vitamin B 12 have been reported (Frederick and Brisson, 1961) . The hepatic reserves in CONT pigs were likely built up through the pre-and postnatal transfer of vitamin B 12 (Simard et al. 2007 ) from their dam fed gestation and lactation diets containing 25 μg of cyanocobalamin/kg. In research by Catron et al. (1952) , pigs were from litters of lactating dams fed a plant protein diet supplemented only with vitamins A and D 2 , and after weaning, these pigs showed symptoms of vitamin B 12 deficiency (growth stasis, in particular) when they were fed a nonsupplemented diet. This apparent saturation of the hepatic pool for vitamin B 12 is further emphasized by the observation that the total amount of vitamin B 12 in liver was maximized at approximately the same amount as that reported by Catron et al. (1952) who observed total contents of 111 and 114 μg of vitamin B 12 after dietary supplementation of 8.8 and 13.2 μg/kg of vitamin B 12 , respectively. After saturation of hepatic tissue, vitamin B 12 reaching the liver would be either redirected toward other tissues or excreted in the bile, and then, entering into the enterohepatic cycle, as observed in sheep (Smith and Marston, 1970) . In the present experiment, the determination of vitamin B 12 in bile from a limited number of pigs showed mean values of 827.5 ± 61.1 (n = 3) and 1,436.9 ± 382.7 (n = 3) pg/mL for B 12 -25 and B 12 -250 pigs, respectively; basal value for CONT pigs was 653.1 ± 89.6 (n = 2). Assuming an average daily bile volume of 2.25 L in pigs of similar BW (Laplace and Ouaissi, 1977; Juste et al., 1979; Sambrook, 1981) , the daily biliary release of vitamin B 12 in B 12 -250 pigs can be estimated to be 3.2 μg as compared with 1.9 μg for B 12 -25 pigs, which are likely of biological importance compared with the estimated daily vitamin B 12 deposition in liver (approximately 2.7 and 2.2 μg/d for B 12 -25 and B 12 -250 pigs, respectively). Bile is considered the second (after the nonabsorbed fecal pool) major route of vitamin B 12 excretion (Hall, 1964) .
The present hepatic responses are also in accordance with findings in other species showing a lack of [
57 Co]vitamin B 12 accumulation in liver after supplementation with greater than 41 μg of vitamin B 12 /kg, indicating the presence of a regulation mechanism for hepatic vitamin B 12 in rats (Birn et al., 2003) . Taking into account that negligible amounts of vitamin B 12 are free in mammalian organs (Kim et al., 2008) , it can be hypothesized that, for pigs, this regulation proceeds through a saturable binding protein system involving transcobalamin II and haptocorrin, similar for the rat (Li et al., 1994; Birn et al., 2003) . In liver, the vitamin is also bound to the 2 intracellular vitamin B 12 -dependent enzymes, cytoplasmic methionine synthase and mitochondrial methylmalonyl-CoA mutase (Combs, 1998) .
The present results on carcass and liver challenge concepts that are related to vitamin B 12 partitioning in the body. Although liver is a major pool of body vitamin B 12 in pigs as reported by Trugo et al. (1985) , hepatic vitamin B 12 represented a maximum of 33 to 40% of the total amount of vitamin B 12 in whole body. In human adults, vitamin B 12 is mainly stored in the liver (about 60% of the total body store) and muscles (about 30% of the total; Le Grusse and Watier, 1993). The ratio of liver to carcass (including muscle, kidney, and blood) in the present study is different than in adult human and could be interpreted as species differences. However, this apparent species difference may be confounded with age because values in reproducing sows of approximately 1 yr of age (300 ng/g; Simard et al., 2007) were approximately 2-fold greater than those observed in the present research.
For the digestive tract, vitamin B 12 supplementation increased concentration and total content even though the latter represented less than 5% of total body vitamin B 12 . It cannot be ruled out that the vitamin B 12 content in digestive tract tissue was influenced in part by the last experimental meal. Indeed, although pigs were fasted 24 h before slaughter, the kinetics of portoarterial differences in trial 2 showed that the duration of absorption process might be longer than 15 h as reported by Chanarin et al. (1978) and Combs (1998) . Therefore, it seems possible that some vitamin B 12 from the previous meal was still sequestered by enterocytes (Seetharam and Yammani, 2003) For urine, samples were collected only from pigs receiving vitamin B 12 supplementation, and the net excretion was twice greater in B 12 -250 than in B 12 -25 pigs. Such response was consistent with Catron et al. (1952) in pigs and Birn et al. (2003) in rats, the latter showing a numerical increase in urinary [
57 Co]B 12 after supplementation with 41 μg of vitamin B 12 /kg. In fact, Birn et al. (2003) proposed a model showing the critical role of kidney for vitamin B 12 homeostasis through a glomerular filtration of the complex transcobalamin-vitamin B 12, followed by renal reuptake of the vitamin. This would explain the large accumulation of vitamin B 12 in kidneys after a vitamin B 12 load in rats. In the present experiment, kidneys were not separated from the carcass.
The whole body retention of vitamin B 12 was greater (P < 0.02) in B 12 -250 than in B 12 -25 pigs. However, for 
Trial 2
Arterial Plasma Concentrations of Vitamin B 12 . Changes in arterial plasma concentrations of vitamin B 12 are illustrated in Figure 1 . Premeal values (time = 0) were not different (P = 0.46) among treatments. After meal, plasma vitamin B 12 decreased (P < 0.01) to reach minimum values between 15 and 18 h postmeal. These minimum values were 29.6, 15.6, and 10.0% less than the premeal values for B 12 -0, B 12 -25, and B 12 -250 pigs, respectively (linear, P < 0.01; cyanocobalamin × time postmeal, P = 0.08). Profiles of vitamin B 12 in peripheral venous blood were reported in humans (von Castel-Roberts et al., 2007) and showed a continuous increase from 1.5 to 6 h postmeal and then a plateau up to 12 h postmeal. It is noteworthy to mention that although the daily dietary B 12 provision was comparable with the present B 12 -25 treatment, it was administered in 3 consecutive 9-μg doses at 6-h intervals. In another report in humans, vitamin B 12 was measured in blood plasma collected from the femoral artery after ingestion of a supplement of 1,000 μg of cyanocobalamin, but the postprandial period was limited to 2 h (Baker et al., 1994) . Thus, those results cannot be compared with the present 24-h profiles. In both studies in humans, profiles were reported in absence of information relative to control diet without vitamin B 12 . To the best of our knowledge, the peculiar feature of the postfeeding arterial responses of vitamin B 12, especially in the B 12 -0 treatment, has never been reported before and likely reflects that the systemic vitamin input from diet or recirculation was less than its output counterpart (i.e., tissue utilization or excretion).
Vitamin B 12 Net Flux. Mean portal net fluxes of vitamin B 12 for 24 h postmeal were 1.02 ± 0.68, 1.83 ± 0.63, and 3.53 ± 0.63 ng/min for B 12 -0, B 12 -25, and B 12 -250 treatments (linear, P < 0.01). For the B 12 -0 treatment, mean portal net flux of vitamin B 12 for 24 h after the meal was not different from 0 (P > 0.15), whereas it was greater than 0 (P < 0.01) for B 12 -25 and B 12 -250 treatments. Throughout the postprandial period, portal net fluxes of vitamin B 12 varied with time (P = 0.05; Figure 2 ), but there was no interaction with treatment (P = 0.98). Positive portal net fluxes different from 0 were observed from 7 to 10 h (P ≤ 0.04), at 13 and 15 h (P = 0.03), and finally 24 h after the meal (P < 0.01). This indicates the presence of at least 2 distinct periods of intestinal absorption, from 7 to 10 h and 13 to 15 h after the meal. Moreover, the fact that the portal net flux was positive (P < 0. [Co]cyanocobalamin (Simnet and Spray, 1965) . Unfortunately, in those 2 last studies, the lack of repeated blood samples beyond 12 h after the meal did not allow for comparisons with the present study. In lactating dairy cows, Girard et al. (2001) indicated that, 24 h after an oral bolus of 0.5 g of cyanocobalamin, the net portal flux of vitamin B 12 showed a biphasic pattern with peaks at 4 to 10 h and 20 to 24 h postmeal. These authors explained that the second peak was the result of the active enterohepatic recirculation, which is known to play a major role in vitamin B 12 homeostasis in ruminants (Smith and Marston, 1970) . If enterohepatic recirculation has the same importance in pigs, it would be compatible with a second and possibly a third episode of intestinal absorption of vitamin B 12 , as observed in the present experiment. This role of biliary recirculation of vitamin B 12 in pigs is further supported by the numerical differences among treatments reported in trial 1 for concentrations of biliary vitamin B 12 .
The cumulative net flux of vitamin B 12 for 24 h corresponded to 2.4 and 5.1 μg for B 12 -25 and B 12 -250 treatments, respectively. Therefore, the efficiency of intestinal absorption was estimated to be 9.7 and 2.0% for B 12 -25 and B 12 -250 treatments, respectively.
Comparison Between the 2 Methods
The estimations of vitamin B 12 absorption based on body retention and urine excretion in trial 1 are consistent with the estimation of intestinal capacity for the vitamin B 12 absorption reported in pigs by Ford et al. (1975) , which was approximately 10 μg per d. The corresponding values for B 12 -25 and B 12 -250 pigs in the present study were 9.6 and 13.3 μg per d, respectively. The inverse relationship between absorption efficiency of vitamin B 12 and dietary cyanocobalamin was also reported for human by Herbert (1987) with absorption efficiencies of 46 and 6% after dietary vitamin B 12 intake of 2 and 20 μg, respectively. In fact, this was also apparent in trial 2, although absolute values were different.
Vitamin B 12 absorption in humans occurs through an active process mediated by ileal intrinsic factor and enterocyte transcobalamin at reduced dietary content (Nicolas and Guéant, 1994) , whereas, at greater dietary content of vitamin B 12 , after saturation with the active absorption process, the excess vitamin would be absorbed by passive intestinal diffusion (Herbert, 1987; Combs, 1998) . If the same explanation applies to pigs, it can be hypothesized that the active absorption was the most important process in B 12 -25 pigs, and consequently, most of the difference of absorption between B 12 -250 and B 12 -25 (13.3 -9.6 = 3.7 μg/d in trial 1) would be due to passive intestinal diffusion. The corresponding calculation for trial 2 was 2.7 μg per d (5.1 to 2.4). In term of percentage of the supplementary dietary vitamin B 12 (250 − 25 = 225 μg), the passive intestinal diffusion would represent approximately 1.6% (3.7/225) and 1.2% (2.7/225) for trials 1 and 2, respectively, which are comparable with the range of 1 to 3% reported for humans (Herbert, 1987) . It seems, therefore, that most of the differences in estimations of bioavailability of dietary vitamin B 12 between the 2 trials were due to the active intestinal absorption process. Both approaches in trials 1 and 2 give an indirect estimation of bioavailability of cyanocobalamin. The retention (trial 1) approach underestimated, in theory, intestinal absorption because part of the vitamin B 12 absorbed during the experimental period of 8 d was used for metabolism and, then, catabolized. On the other hand, the portal appearance approach (trial 2) also underestimated intestinal absorption because part of the vitamin B 12 absorbed after the meal is retained or retained and used directly by the intestinal tissue before reaching the portal vein. In the portal appearance approach, it can be estimated, from results in trial 1, that at least 6 and 9% of the absorbed vitamin B 12 is retained in the digestive tract for B 12 -25 and B 12 -250, respectively. This retention represented, therefore, the minimal amount of absorbed vitamin B 12 , which is not accounted for by the portal appearance approach in trial 2.
Other aspects of the digestive physiology relative to vitamin B 12 might be involved in the differences between the 2 approaches. Some vitamin B 12 can be detected in the lymph of rats (Taylor and French, 1960; Boass and Wilson, 1964) and dogs (Reizenstein et al., 1960) after an oral bolus of vitamin B 12 . The lymph carries vitamin B 12 coming directly from the intestinal lumen and from blood circulation; the former would represent between 3 to 9% of the intestinal absorption of this vitamin (Boass and Wilson, 1964) . If the situation is similar in pigs, it can be hypothesized that a small quantity of vitamin B 12 absorbed through the lymphatic system in trial 2 was not accounted for in the calculation of bioavailability by porto-arterial differences. This could be another contributing factor, although small, for the discrepancy between the 2 approaches for estimation of bioavailability.
In the retention approach in trial 1, each pig received a daily supplement of vitamin B 12 for 8 consecutive days, whereas in trial 2, each pig received each level of supplement only once according to a crossover design. In trial 1, the repeated bolus of supplemental cyanocobalamin along with their successive waves of biliary vitamin B 12 recirculated from the enterohepatic cycle could have gradually enriched the intestinal content in intrinsic factor-bound vitamin B 12 , as reported by Kanazawa et al. (1985) . Moreover, vitamin B 12 from this endogenous source was possibly more bioavailable than the dietary source because, in other species such as baboons, cobalamin from bile is better absorbed and retained than cyanocobalamin (Green et al., 1982) . Although all the aforementioned factors related to digestive physiology of vitamin B 12 can contribute to differences of bioavailability measurements between the 2 trials, their relative importance cannot be determined with the present available information.
In summary, although the estimations of bioavailability varied according to the approach chosen, it was nevertheless possible to differentiate the impact of dietary vitamin B 12 on its bioavailability as previously reported for humans. A daily dietary supplementation of 25 μg, which is greater than NRC (1998) recommendation (15 μg/kg) but similar to the level commonly used by the industry (BASF, 2001) , seemed adequate to maximize vitamin B 12 in liver (trial 1) and to attenuate the nycthemeral decrease in arterial plasma concentrations of vitamin B 12 (trial 2). Although the bioavailability of vitamin B 12 was apparently substantially decreased with a daily dietary supplementation with 250 μg, such a supplement could build up whole body reserves (carcass and digestive tract) by up to 40% (trial 1) or doubled the cumulative net flux of the vitamin across portal-drained viscera (trial 2) over a supplementation with 25 μg.
LITERATURE CITED
